Stock Analysis on Net

Medtronic PLC (NYSE:MDT)

$24.99

Price to Earnings (P/E)
since 2005

Microsoft Excel

Paying user area


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Calculation

Medtronic PLC, P/E, long-term trends, calculation

Microsoft Excel

Based on: 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24), 10-K (reporting date: 2019-04-26), 10-K (reporting date: 2018-04-27), 10-K (reporting date: 2017-04-28), 10-K (reporting date: 2016-04-29), 10-K (reporting date: 2015-04-24), 10-K (reporting date: 2014-04-25), 10-K (reporting date: 2013-04-26), 10-K (reporting date: 2012-04-27), 10-K (reporting date: 2011-04-29), 10-K (reporting date: 2010-04-30), 10-K (reporting date: 2009-04-24), 10-K (reporting date: 2008-04-25), 10-K (reporting date: 2007-04-27), 10-K (reporting date: 2006-04-28), 10-K (reporting date: 2005-04-29).

1 US$

2 Data adjusted for splits and stock dividends.

3 Closing price as at the filing date of Medtronic PLC Annual Report.


Share Price Trend
The share price exhibits considerable fluctuations over the reported period. It initially declined from $52.20 in 2005 to a low of $33.37 in 2009. Subsequently, there was a general upward trend peaking at $124.93 in 2021. After this peak, the share price decreased notably to $80.17 in 2024, followed by a modest increase to $86.34 in 2025.
Earnings Per Share (EPS) Trend
EPS demonstrated variable performance, starting at $1.49 in 2005 and increasing to $3.53 in 2008. A decline to $1.89 occurred by 2015. From 2016 onward, EPS fluctuated, reaching a high of $3.79 in 2022, before experiencing a drop in 2023 and a recovery to $3.64 by 2025. Overall, the EPS trend indicates intermittent growth amid periods of volatility.
Price-to-Earnings (P/E) Ratio Trend
The P/E ratio showed significant variability. It started high at 35.12 in 2005, falling to a low of 10.57 in 2012, indicating relatively lower valuation at that time. Thereafter, it increased with notable peaks such as 46.56 in 2021 and 40.56 in 2015, reflecting periods when share prices were high relative to earnings. Towards 2025, the P/E ratio settled around 23.73, indicating a moderate valuation level compared to past years.
Interrelations and Insights
The share price movements generally correlate with EPS changes, though not perfectly. For instance, large EPS increases do not always correspond to proportional share price increases, suggesting other market factors influencing valuation. Periods of low EPS were sometimes associated with higher P/E ratios, possibly reflecting market anticipation or other external influences. The volatility in P/E ratios indicates fluctuating investor sentiment regarding the company’s earnings prospects throughout the period.

Comparison to Competitors

Medtronic PLC, P/E, long-term trends, comparison to competitors

Microsoft Excel

Based on: 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24), 10-K (reporting date: 2019-04-26), 10-K (reporting date: 2018-04-27), 10-K (reporting date: 2017-04-28), 10-K (reporting date: 2016-04-29), 10-K (reporting date: 2015-04-24), 10-K (reporting date: 2014-04-25), 10-K (reporting date: 2013-04-26), 10-K (reporting date: 2012-04-27), 10-K (reporting date: 2011-04-29), 10-K (reporting date: 2010-04-30), 10-K (reporting date: 2009-04-24), 10-K (reporting date: 2008-04-25), 10-K (reporting date: 2007-04-27), 10-K (reporting date: 2006-04-28), 10-K (reporting date: 2005-04-29).


Comparison to Sector (Health Care Equipment & Services)


Comparison to Industry (Health Care)